Keyword Suggestion
Domain Informations
Network
- inetnum : 23.192.0.0 - 23.223.255.255
- name : AKAMAI
- handle : NET-23-192-0-0-1
- status : Direct Allocation
- created : 1999-01-21
- changed : 2023-10-24
Owner
- organization : Akamai Technologies, Inc.
- handle : AKAMAI
- address : Array,Cambridge,MA,02142,US
Technical support
- handle : SJS98-ARIN
- name : Schecter, Steven Jay
- phone : +1-617-274-7134
- email : [email protected]
Abuse
- handle : NUS-ARIN
- name : NOC United States
- phone : +1-617-444-2535
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 23.222.241.42
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 23.222.241.42)
Spam Check (IP: 23.222.241.42)
Recent Searched Sites
› Mazzotta.intemposoftware.com (16 seconds ago) / US
› Radford.edu (2 seconds ago) / US
› Gleecbd.com (6 seconds ago) / US
› Windsor.portals.in-part.com (3 seconds ago) / IE
› Auto.matrixplus.ru (5 seconds ago) / RU
› Cpz.com (2 seconds ago) / US
› Yume922.com (23 seconds ago) / US
› X7bet.site (14 seconds ago) / US
› Aufastgame2025.com (2 seconds ago) / RU
› Us.triumeq.com (1 seconds ago) / US
› Chiprimesemiconductor.com (12 seconds ago) / IN
› Jinshanmz.com (11 seconds ago) / CN
› Combook.lookme-e.com (28 seconds ago) / JP
› Peceprogram.net (4 seconds ago) / US
› Puenteromano.com (8 seconds ago) / GB
› Shoen001.com (5 seconds ago) / US
› Buan.go.kr (6 seconds ago) / KR
› Powersemilab.com (2 seconds ago) / CN
› Foxcargo.com.br (3 seconds ago) / US
› Omnivitylogistics.com (2 seconds ago) / PL
Websites Listing
We found Websites Listing below when search with us.triumeq.com on Search Engine
Home | TRIUMEQ Official HCP Website
Administer TRIUMEQ 2 hours before or 6 hours after taking antacids, polyvalent cation-containing products or laxatives, sucralfate, oral supplements containing iron or calcium, or buffered medications. Alternatively, TRIUMEQ and supplements containing calcium or …
Triumeqhcp.comTRIUMEQ. TRIUMEQ (abacavir, dolutegravir, and …
TRIUMEQ is contraindicated in patients with a prior hypersensitivity reaction to abacavir and in HLA-B*5701-positive patients. (4) • Discontinue TRIUMEQ as soon as a hypersensitivity reaction is suspected. Regardless of HLA-B*5701 status, permanently discontinue TRIUMEQ if hypersensitivity cannot be ruled out, even when other diagnoses are ...
Accessdata.fda.govTriumeq, Triumeq PD (abacavir/dolutegravir/lamivudine ...
The Centers for Disease Control and Prevention does not recommend HIV-1-infected mothers in the United States breastfeed their infants to avoid the risk of postnatal transmission of HIV-1 infection. Abacavir and lamivudine are present in human milk. When administered to lactating rats, dolutegravir was present in milk
Reference.medscape.comViiV Healthcare announces US FDA approval of Triumeq PD ...
2022-04-01 · TRIUMEQ and TRIUMEQ PD are contraindicated in patients with a prior hypersensitivity reaction to abacavir and in HLAB*5701-positive patients. All patients should be screened for the HLA-B*5701 allele prior to initiating therapy or reinitiation of therapy with TRIUMEQ or TRIUMEQ PD unless patients have a previously documented HLA-B*5701 allele …
Pharmiweb.comUS FDA approves ViiV’s Triumeq PD for children
2022-03-31 · US FDA approves ViiV’s Triumeq PD for children 31-03-2022 Print. More on this story. Article US approval for Apretude in HIV first. 21-12-2021 . Article ViiV Healthcare filing seeks to address children’s gap in access to HIV treatments. 04-10-2021. Article ViiV Healthcare inks exclusive license deal with Shionogi; files PrEP candidate. 28-09-2021. Other stories of …
Thepharmaletter.comViiV Healthcare Announces US FDA Approval of Triumeq PD ...
ViiV Healthcare Announces US FDA Approval of Triumeq PD, the First Dispersible Single Tablet Regimen Containing Dolutegravir, a Once-Daily Treatment for Children Living with HIV. London, 30 March 2022 – ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (Pfizer) and Shionogi B.V. (Shionogi) as …
Drugs.comViiV Healthcare receives FDA green light for Triumeq ...
2022-04-06 · Triumeq is a dispersible tablet formulation of the fixed-dose combination of abacavir, dolutegravir and lamivudine for the treatment of pediatric patients weighing 10kgs to <25 kgs with human ...
Drugstorenews.comTRIUMEQ® | ViiV Healthcare Canada
Reporting an adverse event. Your own healthcare professional is the best source of information regarding your health. If you need to report an adverse event for any ViiV Healthcare Canada product, please call 1-877-393-8448.
Viivhealthcare.comBRIEF-ViiV Healthcare Says U.S FDA Approved Triumeq PD For ...
2022-03-30 · * viiv-us fda approval of triumeq pd,first dispersible single tablet regimen containing dolutegravir, once-daily treatment for children living with hiv
Reuters.comAbacavir / Dolutegravir / Lamivudine - Patient | NIH
2021-09-02 · If you get a symptom from two or more of the following groups while taking Triumeq or Triumeq PD, contact your health care provider right away to find out if you should stop taking Triumeq or Triumeq PD. Group 1 Symptoms: Fever; Group 2 Symptoms: Rash; Group 3 Symptoms: Nausea, vomiting, diarrhea, stomach/abdominal pain; Group 4 Symptoms: …
Clinicalinfo.hiv.govTriumeq: Scheda Tecnica e Prescrivibilità - Torrinomedica
2021-07-20 · Triumeq non è raccomandato per l’impiego nei pazienti con una clearance della creatinina < 50 mL/min (vedere paragrafo 5.2). Compromissione epatica. Abacavir è principalmente metabolizzato dal fegato. Non sono disponibili dati clinici nei pazienti con compromissione epatica moderata o severa, pertanto l’impiego di Triumeq non è ...
Torrinomedica.itViiV Healthcare announces US FDA approval of Triumeq PD ...
2022-03-30 · ViiV Healthcare announces US FDA approval of Triumeq PD, the first dispersible single tablet regimen containing dolutegravir, a once-daily treatment for children living with HIV The FDA approval of the first dispersible single tablet regimen containing dolutegravir increases age-appropriate treatment options for children living with HIV. London, 30 March 2022 – ViiV …
Positivelypositive.caTriumeq Coupon & Prices - Cost $49 per month - NiceRx
Triumeq contains three active ingredients: abacavir, dolutegravir, and lamivudine. The HIV-1 virus copies itself by invading your T-helper white blood cells. It inserts itself into the DNA inside the cells, then takes advantage of your natural DNA copying process to make copies of itself. Eventually, the T-cell dies, and copies of the HIV-1 virus spread to other T-cells, and the cycle ...
Nicerx.comTriumeq - 快懂百科 - Baike.com
2014年8月份，三合一HIV药物Triumeq（dolutegravir/abacavir/lamivudine，dolutegravir/阿巴卡韦/拉米夫定，50mg/600mg/300mg）获美国FDA批准 ...
Baike.comGlaxo (GSK) Eyes Nod for Triumeq Expanded Use in Pediatric ...
2021-10-05 · Glaxo’s regulatory submission seeks approval for a new dispersible tablet formulation of Triumeq, which is a fixed-dose combination of abacavir, dolutegravir and lamivudine, for children with ...
Nasdaq.comANEXO I RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO
Triumeq inclui lamivudina, que é ativa contra a hepatite B. O abacavir e o dolutegravir não possuem tal atividade. A monoterapia com lamivudina não é habitualmente considerada um tratamento adequado para a hepatite B, uma vez que o risco de desenvolvimento de resistência à hepatite B é elevado. Se Triumeq for utilizado em doentes coinfetados com hepatite B, …
Ema.europa.eu
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| streamtimer.com | godaddy.com | -3 Years, -76 Days |
| thevinery.co | whois.godaddy.com | 1 Year, 56 Days |
| ediket.com | registrar.amazon.com | -3 Years, -226 Days |
| imprensadehoje.com | namecheap.com | -3 Years, -168 Days |
| theeatdown.com | godaddy.com | -2 Years, -176 Days |
| tricehughesgm.com | markmonitor.com | -3 Years, -24 Days |
| kouseisha.com | gmo.jp | -3 Years, -103 Days |
| lowryrv.com | godaddy.com | -3 Years, -212 Days |
| ahoybikes.com | godaddy.com | -3 Years, -256 Days |
| hpcs.com | cscdbs.com | -3 Years, -300 Days |